ニュース

As NICE begins to incorporate health equity into drug reimbursement decisions, forward-looking pharmaceutical companies have ...
The UK exported £127 million in medicinal and pharmaceutical products to India in 2024, according to the organisation's ...
AstraZeneca and Daiichi Sankyo's anti-HER2 drug Enhertu has been shown to provide a benefit in a phase 3 trial in early-stage ...
The data used to train the AI – including vaccination records, GP visits, hospital admissions, and A&E attendances – is being ...
The aim is to make sure that foreign companies "receive the same level of regulatory oversight and scrutiny as domestic ...
Controversial doctor Vinay Prasad, a public health researcher at UCSF known as a critic of US health policy, has been named ...
A filing by the Department of Justice has asked Judge Matthew Kacsmaryk, a Trump appointee who opposes abortion, to block the ...
The phase 2 PIVOT-HD trial of Novartis-partnered PTC518 (votoplam) showed that the oral mRNA splicing modifier was able to ...
Financial terms of the new agreement include an upfront payment to secure rights to Alchemab's lead ALS candidate, ATLX-1282, ...
The NEJM has fired back a response to the Department of Justice (DoJ) asserting its "commitment to evidence-based ...
Merck KGaA has reached an agreement with SpringWorks on a $47-per-share takeover deal that values the US biotech at $3.9 ...
That is according to the chief executive of the American Association for the Advancement of Science (AAAS), Sudip Parikh, who ...